NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q1 2024. The put-call ratio across all filers is 9.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16,234,973 | -46.0% | 1,928,144 | -7.5% | 0.08% | -47.0% |
Q1 2024 | $30,088,440 | -34.0% | 2,083,687 | -1.7% | 0.15% | -39.4% |
Q4 2023 | $45,606,604 | +125.2% | 2,119,266 | +101.1% | 0.25% | +112.1% |
Q3 2023 | $20,254,266 | -26.7% | 1,053,812 | -3.0% | 0.12% | -17.7% |
Q2 2023 | $27,629,939 | -34.9% | 1,086,937 | -7.4% | 0.14% | -37.9% |
Q1 2023 | $42,448,885 | -9.5% | 1,174,243 | -0.8% | 0.23% | -10.6% |
Q4 2022 | $46,886,400 | +7.8% | 1,184,000 | +26.9% | 0.25% | +15.5% |
Q3 2022 | $43,487,000 | -19.7% | 933,195 | -24.5% | 0.22% | -13.0% |
Q2 2022 | $54,186,000 | -19.3% | 1,236,289 | +33.2% | 0.25% | +18.2% |
Q1 2022 | $67,119,000 | -7.9% | 927,960 | +3.3% | 0.21% | +17.6% |
Q4 2021 | $72,850,000 | -48.4% | 898,602 | -25.9% | 0.18% | -46.0% |
Q3 2021 | $141,137,000 | -65.6% | 1,212,721 | -51.0% | 0.34% | -65.2% |
Q2 2021 | $410,149,000 | +34.5% | 2,473,909 | +13.2% | 0.97% | +21.3% |
Q1 2021 | $304,947,000 | -17.5% | 2,186,002 | +2.3% | 0.80% | -17.0% |
Q4 2020 | $369,848,000 | +25.4% | 2,136,612 | +0.9% | 0.96% | +12.4% |
Q3 2020 | $294,888,000 | +18.6% | 2,116,926 | +1.7% | 0.86% | +4.5% |
Q2 2020 | $248,659,000 | -37.2% | 2,081,355 | -47.5% | 0.82% | -6.0% |
Q1 2020 | $396,120,000 | +76.1% | 3,961,992 | +107.0% | 0.87% | +5.2% |
Q4 2019 | $224,967,000 | +38.2% | 1,913,958 | +1.1% | 0.83% | +29.6% |
Q3 2019 | $162,778,000 | +142.1% | 1,893,423 | +82.6% | 0.64% | +147.7% |
Q2 2019 | $67,227,000 | +11.2% | 1,036,977 | +7.2% | 0.26% | +7.1% |
Q1 2019 | $60,458,000 | +191.4% | 967,176 | +81.3% | 0.24% | +151.0% |
Q4 2018 | $20,749,000 | +98704.8% | 533,521 | +188423.3% | 0.10% | – |
Q2 2017 | $21,000 | -99.2% | 283 | -99.0% | 0.00% | -100.0% |
Q1 2017 | $2,699,000 | -40.2% | 28,800 | -53.7% | 0.01% | -48.0% |
Q4 2016 | $4,515,000 | +72.6% | 62,140 | +148.0% | 0.02% | +92.3% |
Q3 2016 | $2,616,000 | +153.2% | 25,059 | +79.0% | 0.01% | +160.0% |
Q2 2016 | $1,033,000 | +22.4% | 14,000 | -6.7% | 0.01% | +25.0% |
Q1 2016 | $844,000 | -18.3% | 15,000 | -2.0% | 0.00% | -20.0% |
Q4 2015 | $1,033,000 | -86.3% | 15,300 | -90.2% | 0.01% | -85.3% |
Q1 2015 | $7,516,000 | +10.3% | 156,811 | -11.0% | 0.03% | +3.0% |
Q4 2014 | $6,815,000 | – | 176,239 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
Olympiad Research LP | 25,046 | $210,887 | 0.16% |